Adaptive Immune System - B and T Cells Flashcards

1
Q

What is the first response to infection?

When the first line of defence fails, what is there as the ‘back-up’?
- List the two branches of adaptive immunity, and what mediates them.

A

The first response to an infection would be the innate immune system. It has a rapid response and is non-specific (working with generic anti-bacterial or anti-viral mechanisms).
Most of the time, it fails to completely eliminate the infection.

As a back-up in case the innate immune system fails, the adaptive immune system is present.
It has a delayed response, but is highly specific in targeting an infection. It usually eliminates the infection, and in the process, creates a ‘memory’, providing the body with long-term immunity from that specific pathogen.
Some pathogens can evade this system by mutating rapidly.

The two branches of adaptive immunity are:
- HUMOURAL IMMUNITY: mediated by B-lymphocytes, the plasma will contain antibodies
- CELLULAR IMMUNITY: mediated by CD8 and cytotoxic T-lymphocytes

Both of these branches are regulated by CD4 and helped T-lymphocytes (T-helped cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the structure and function of antibodies.

A

STRUCTURE:
It is an immunoglobulin glycoprotein released by plasma cells (differentiated B-cells). It is Y shaped and tetrameric, made up of 2 identical light chains and 2 identical heavy chains. These are held together by non-covalent interactions and S-S crosslinks between cysteine residues.

Each antibody has a variable region, which is where the amino acid sequence varies from one Ig molecule to the other. It is the part of the antibody that binds the antigen.
Each antibody also has a constant region, which is responsible for the effector functions of the antibody (ie. what the Ig will do after binding, for example, activating complement, binding to phagocytes)

Each Ig molecule has two antigen binding sites and a flexible hinge region. If you were to cut the antibody at the hinge region, you would end up with two fragments. The two fragments are:
- Fab-fraction: antigen binding
- Fc-fraction: crystallisable because it’s not variable

FUNCTION:
Can fight infection in 3 different ways
1) BY COATING AND NEUTRALISING A PATHOGEN:
eg. if a virus is coated with antibodies, it cannot bind to its receptors on the cell surface

2) BY ACTIVATING COMPLEMENT:
- these can then blow holes in a bacterial cell membrane
- these can also act as chemoattractants for opsonisation and phagocytes

3) BY OPSONISATION
- phagocytes have Fc (for the antibody Fc-fraction) receptors on their cell membrane
- they bind to pathogens coated with antibodies, and phagocytose them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does an antibody bind to an antigen?

With this in mind, does the body design specific antibodies to bind to specific antigens?

A

It does so through non-covalent interactions: electrostatic, hydrophobic, van der Waals forces, hydrogen bonds.
This depends on the antibody binding site being exactly complementary, sterically (shape-wise) and chemically, with a site on the surface of the antigen.

The binding site on the antigen for one specific antibody is called an EPITOPE.

Does the body design specific antibodies to bind to specific antigens?

No, it doesn’t; instead, the body generates over 100,000,000 different B-cells, each making a ‘random’ immunoglobulin. These naive B-cells wait around in the lymph nodes.
During an infection, a small number of B-cells will, by chance, be making an immunoglobulin that binds to one of the foreign antigens. These B-cells are then activated and begin to multiply to make more of that specific immunoglobulin. This is known as ‘clonal selection’.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe lymphocyte development in the bone marrow.

A

First, we have a haematopoietic stem cell. This can differentiate to either a common myeloid progenitor or a common lymphoid progenitor. The common myeloid progenitor goes on to differentiate into red blood cells, platelets, etc.
The common lymphoid progenitor differentiates into either a pre-T-cell or a pre-B-cell. The pre-T-cell is sent for further development to the thymus. The pre-B-cell rearranges its Ig genes, to make a possible combination for a certain Ig. It then becomes an immature B-cell, awaiting activation.
These immature B-cells are sent to secondary lymphoid organs, such as the lymph nodes, spleen, gut, etc. They sit in follicles on the organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the role of immunoglobulin in B-cell activation.

A

Functional Ig is first expressed as IgM on the cell surface (mIgM). This acts as a ‘B-Cell receptor’ in a similar way to a growth factor receptor. The IgM doesn’t have intrinsic tyrosine kinase activity (as it’s not joined to the protein on the inside), but it associates with other tyrosine kinases (in the cytosol).
The binding of an antigen to IgM activates the tyrosine kinases and their signal transduction pathways. In essence, the IgM is acting as a cell signalling receptor. If an antigen doesn’t bind to this B-cell, it will sit in the lymph node and eventually die by apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does the activation of B-cells require?
Follow up with explaining the end results of activation of B-cells.

A

It requires:
- an antigen binding to the B-cell receptor (mIgM), resulting in stimulation of signal transduction pathways
- the co-stimulation by T-cells (this is becuase the immune system is very tightly regulated)

The activated B-cell then begins to secrete soluble IgM (sIgM). The activated B-cells multiply rapidly and differentiate into either Ig-secreting cells or memory B-cells.

Ig-secreting cells first make IgM, but then undergo class switching to make IgG, IgA, etc.
Memory B-cells survive for a long time after infection. They allow the very rapid response spoken about earlier to second exposure. It results in the immediate production of IgG, rather than IgM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe class (or isotype) switching.

A

Once a B-cell starts making an immunoglobulin which binds a specific antigen, it can switch to making immunoglobulins with the same antigen-binding site, but different constant regions.
This is so that they can carry out different functions in different parts of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the different classes of immunoglobulins?

A
  • IgA
  • IgM
  • IgG
  • IgD
  • IgE

Note that there are actually four subclasses of IgG (IgG1 - IgG4) and two subclasses of IgA (IgA1 and IgA2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe IgM.

A

Membrane-bound IgM (mIgM) is formed of a single Ig tetramer, while in the secreted IgM (sIgM), five moecules of the basic Ig tetramer polymerise to form a pentamer.

It is always the first class of immunoglobulin made by B-cells during the primary response.
It is first made a membrane-bound protein (mIgM) in the B-cell surface, which activates the B-cell by signal transduction. Later, it is made in a secreted form (sIgM), which activates complement and acts as an opsonin.

Thus, it can be used as an indicator of a primary response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe IgA.

A

Most abundant class in external secretions (eg. milk, sweat, tears, gut secretions). It protects mucosal surfaces.
It doesn’t activate complement (makes sense becuase complement are found in the plasma while IgA is found mainly in secretions). It does, however, bind to Fc receptors, triggering phagocytosis and inflammatory reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe IgG and IgE.

A

IgG
It is a major class on Ig in the circulation. It is very good at activating the complement system, and it’s also good as an opsonin.

It is formed from a single Ig tetramer.

IgE
IgE has a physiological role in protection against parasitic worms; it binds to Fc receptors on mast cells and basophils and triggers the release of histamine.
IgE is also involved in allergies, as it is produced in response to allergens (eg. pollen, peanuts, etc.). The release of histamine causes the symptoms of these allergies; an over response can cause anaphylactic shock.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe IgD.

A

We still don’t know exactly what it does as its role is unknown.

It is found in extremely low concentrations in circulation. It is also found on the B-cell membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the lymphoid progenitor cell.

A

Gives rise to lymphocytes.
Upon activation by antigens, they become effector cells or memory cells.

There are two main types: T-cells and B-cells (T-lymphocytes and B-lymphocytes). In the early developmental stage, cells can either pass to the thymus (and become T-cells) or stay in the bone marrow (and become B-cells).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the role of the thymus in T-cell development.

A

T-cells mature in the thymus.
Immature T-cells develop in the bone marrow then migrate to the thymus to encounter self-antigens.
During this process, many T-cells die by apoptosis, leaving just those that can generate a useful response to infection.

The thymus enlarges during childhood, then atrophies at puberty.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List and describe the four T-cell subsets.

A
  • αβ T-cells (helper T-cells) (express CD4 and CD3):
  • activated to secrete cytokines to help immune responses, or become memory cells
  • two main subgroups: TH1 and TH2 (also Th17)
  • Cytotoxic T-cells (express CD8 and CD3):
  • activated to kill infected targets, or to become memory cells
  • usually cytotoxic in nature and kill via the release of the toxic contents of granules, or induction of apoptosis
  • Regulatory T-cells:
  • mainly CD4+ (some CD8+) cells able to affect immune responses by either suppressing them or activating them through direct cell contact or by the secretion of soluble factors (cytokines)
  • two types: natural or inducible
  • γδ T-cells:
  • T-cell receptor (TCR) formed of the γδ chain recognise lipid antigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the T-cell receptor (TCR).

A

Dimeric molecule made up of either αβ or γδ chains linked by disulphide links.
Each chain has a variable and a constant Ig-like domain. The variable region has hypervariable regions which are antigen binding sites.
It’s associated with the signalling complex CD3 (CD3 is the identifier of the T-cell).

17
Q

Describe the Major Histocompatibility Complex (MHC).

A

Present on T-cells; it’s a surface-expressed molecule which binds peptides derived from antigens.
MHC encodes for human leukocyte antigens (HLA).

There are two types of MHCs:
- MHC Class I (HLA-A,B and C), expressed on all nucleated cells
- MHC Class II (HLA-D), expressed on ‘professional’ antigen-presenting cells (dendritic cells and macrophages).

MHC I is made of an α chain and β2-microglobulin; it is recognised by CD8+ T cells.
MHC II is made of an α chain and β chain; it is recognised by CD4+ T cells .

18
Q

What are the steps for antigen processing and presentation to CD4 cells?

A

There is first uptake of the pathogen into a phagosome, which fuses with a lysosome to form a phagolysosome. The proteins are chopped up and peptides generated from the bacteria These vesicles containing the bacterial peptides travel around until they meet vesicles containing MHC molecules. The
MHC is generated in the ER (alpha and beta chains) and then assembled, MHC II always needs to contain some peptide or the chains come apart. In the ER there is a protein called the invariant chain which sits in the groove between the chain and stabilises it.
MHC II is transported in exocytic vesicles to the membrane, if the cell contains bacterial peptides in vesicles, the two will usually meet and if the peptide fits well into MHC II, then the pathogen peptide displaces the invariant chain and sits in the groove.
This peptide-MHC complex is then presented on the cell surface.

19
Q

What are the steps for antigen processing and presentation to CD8 cells?

A

The cell doesn’t need to be an antigen-presenting cell, but it does have to have a nucleus. If virus enters the cell, it will be free in the cytosol. The virus will start to replicate their viral proteins, so these viral proteins will be in the cytosol. The viral proteins undergo ubiquination/gets ubiquinated (get tagged with a polymer of ubiquitin). This targets it to be degraded by a proteasome, which chops up the viral protein into peptides which enter into the cytosol. The peptides get transported into the ER and get chopped up to even smaller pieces, where they fit the shape of the groove in the MHC I molecule. The MHC I – viral peptide molecule is then transported to the membrane and presented on the surface where it can be recognized by CD8+ T cells.

20
Q

List some antigen-presenting cells.

A
  • dendritic cells
  • tissue specific dendritic cells
  • macrophages
  • B-cells
  • endothelial cells under some conditions
21
Q

What happens to T-cells in the thymus?

A

T-cells in the thymus enter as thymocytes, not expressing either CD4 nor CD8 (double negative), go through a stage of expressing both (double positive), followed by a decision to be either CD4+ or CD8+.
They are positively selected to bind to molecules called MHC, and negatively selected if they bind self-peptides (‘education’).

22
Q

Describe CD4 T cells.

A

They recognise a peptide in the binding groove of MHCII.
- T helped cells: produce a cytokine profile which directs the immune response to a certain outcome
- T-regulatory cells: responsible for ending an immune response

23
Q

Describe CD4+ Th1 and CD4+ Th2 cells.

A

CD4+ Th1 Cells
- Express the co-receptor CD4. They help to activate the cellular immune response (it activates macrophages and cytotoxic T-cells). It produces the γ-interferon.
- Th1 responses are effective against intracellular infections, bacterial, protozoal and viral.
- Th1 and Th2 are mutually antagonistic.

CD4+ Th2 Cells
- Express the co-receptor CD4. They help to activate the humoural immune response. They produce interleukin 4, 5 and 13.
- They activate B-cells to produce antibodies.
- Th2 responses are effective against extracellular cellular infections, bacterial, protozoal and viral. They’re effective in IgE production against helminth (worm) infections.
- Th1 and Th2 are mutually antagonistic.

24
Q

Describe CD4+ Th17 cells.

A

Expresses the co-receptor CD4. They help to protect gut mucosa. They produce interleukin 17 and 22. It recruits neutrophils to sites of infection.

Th17 responses are effective against extracellular bacteria and fungi. It’s effective in promoting neutrophil-mediated inflammation and helping Th1 cells to induce phagocytosis and subsequent killing of pathogens.

25
Q

Describe CD4+ Treg cells.

A

Express the co-receptor CD4, CD25 and FoxP3.
They maintain immune tolerance and suppress immune responses. They produce anti-inflammatory cytokines IL10 and TGFβ. They also have a contact-dependant immunosuppressive effect.

Tregs inhibit the effector functions of CD4+ and CD8+ T-cells. Also, they inhibit the antigen presentation function of B-cells and other antigen-presenting cells.

26
Q

Describe CD8+ cytotoxic T-cells (CTL) and their mechanism of action.

A

Express the co-receptor CD8. They eliminate intracellular functions. They produce IL2, TNFα and γIFN. They also have a role in anti-tumour immunity and rejection of transplants.

They kill infected cells in an antigen-specific and cell-contact-dependent manner.

MECHANISM OF ACTION
Contact with the cell delivers a ‘lethal hit’.
It releases cytolytic molecules from its intracellular stores that trigger apoptosis in the target cell.
The CTL can then detach and target another cell.

27
Q

Describe the CTL cytolytic proteins.

A

PERFORIN: forms pores in target cell membranes, allowing the entry of granzymes
GRANZYMES (A, B, and C): serine-esterase proteases that induce apoptosis

This acts at a specific synapse between the CTL and the target, thus limiting any ‘collateral’ damage. It involved cytoskeletal reorganisation and granule release.

Granzymes activate caspases, which lead to apoptosis (Granzyme B can trigger the mitochondrial apoptotic pathway).
FasL (on the CTL) ligates the Fas receptor (on target cells), which also leads to the activation of caspases, which ultimately leads to apoptosis.

The killing of infected cells by CTL eliminates the reservoirs of infection.